129 related articles for article (PubMed ID: 8554791)
21. [Molecular analysis of the IT15 gene in 79 Spanish families with Huntington's disease: diagnostic confirmation and presymptomatic diagnosis].
Sánchez A; Milà M; Castellví-Bel S; Calopa M; Genís D; Jiménez D; Estivill X
Med Clin (Barc); 1997 May; 108(18):687-90. PubMed ID: 9324583
[TBL] [Abstract][Full Text] [Related]
22. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
[TBL] [Abstract][Full Text] [Related]
23. Cognitive and psychiatric aspects of Huntington disease contribute to functional capacity.
Nehl C; Paulsen JS;
J Nerv Ment Dis; 2004 Jan; 192(1):72-4. PubMed ID: 14718780
[No Abstract] [Full Text] [Related]
24. [Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].
Robert PH; Schuck S; Dubois B; Lépine JP; Gallarda T; Olié JP; Goni S; Troy S
Encephale; 2003; 29(3 Pt 1):266-72. PubMed ID: 12876552
[TBL] [Abstract][Full Text] [Related]
25. Correlates of early disability in Huntington's disease.
Mayeux R; Stern Y; Herman A; Greenbaum L; Fahn S
Ann Neurol; 1986 Dec; 20(6):727-31. PubMed ID: 2949692
[TBL] [Abstract][Full Text] [Related]
26. The relationship between CAG repeat length and clinical progression in Huntington's disease.
Ravina B; Romer M; Constantinescu R; Biglan K; Brocht A; Kieburtz K; Shoulson I; McDermott MP
Mov Disord; 2008 Jul; 23(9):1223-7. PubMed ID: 18512767
[TBL] [Abstract][Full Text] [Related]
27. Natural history of Huntington disease.
Dorsey ER; Beck CA; Darwin K; Nichols P; Brocht AF; Biglan KM; Shoulson I;
JAMA Neurol; 2013 Dec; 70(12):1520-30. PubMed ID: 24126537
[TBL] [Abstract][Full Text] [Related]
28. The association of CAG repeat length with clinical progression in Huntington disease.
Rosenblatt A; Liang KY; Zhou H; Abbott MH; Gourley LM; Margolis RL; Brandt J; Ross CA
Neurology; 2006 Apr; 66(7):1016-20. PubMed ID: 16606912
[TBL] [Abstract][Full Text] [Related]
29. Severity of cognitive impairment in juvenile and late-onset Huntington disease.
Gómez-Tortosa E; del Barrio A; García Ruiz PJ; Pernaute RS; Benítez J; Barroso A; Jiménez FJ; García Yébenes J
Arch Neurol; 1998 Jun; 55(6):835-43. PubMed ID: 9626775
[TBL] [Abstract][Full Text] [Related]
30. Are cognitive changes the first symptoms of Huntington's disease? A study of gene carriers.
Hahn-Barma V; Deweer B; Dürr A; Dodé C; Feingold J; Pillon B; Agid Y; Brice A; Dubois B
J Neurol Neurosurg Psychiatry; 1998 Feb; 64(2):172-7. PubMed ID: 9489526
[TBL] [Abstract][Full Text] [Related]
31. [Neuropsychological evaluation can contribute to the diagnosis of movement disorders].
Dubois B; Beato R; Villalpando JM
Rev Neurol (Paris); 2003 May; 159(5 Pt 2):3S50-6. PubMed ID: 12773888
[TBL] [Abstract][Full Text] [Related]
32. The current clinical management of Huntington's disease.
Phillips W; Shannon KM; Barker RA
Mov Disord; 2008 Aug; 23(11):1491-504. PubMed ID: 18581443
[TBL] [Abstract][Full Text] [Related]
33. A four-year prospective study of cognitive functioning in Huntington's disease.
Ward J; Sheppard JM; Shpritz B; Margolis RL; Rosenblatt A; Brandt J
J Int Neuropsychol Soc; 2006 Jul; 12(4):445-54. PubMed ID: 16981596
[TBL] [Abstract][Full Text] [Related]
34. [Molecular diagnosis of Huntington's disease: an analysis of two large families].
Zeng Y; Chen M; Mao Y
Zhonghua Yi Xue Za Zhi; 1995 Nov; 75(11):689-93, 711-2. PubMed ID: 8697093
[TBL] [Abstract][Full Text] [Related]
35. Objective assessment of motor slowness in Huntington's disease: clinical correlates and 2-year follow-up.
van Vugt JP; Piet KK; Vink LJ; Siesling S; Zwinderman AH; Middelkoop HA; Roos RA
Mov Disord; 2004 Mar; 19(3):285-97. PubMed ID: 15022182
[TBL] [Abstract][Full Text] [Related]
36. Plasma testosterone in male patients with Huntington's disease: relations to severity of illness and dementia.
Markianos M; Panas M; Kalfakis N; Vassilopoulos D
Ann Neurol; 2005 Apr; 57(4):520-5. PubMed ID: 15786456
[TBL] [Abstract][Full Text] [Related]
37. Anosognosia in Alzheimer's disease: association with patient characteristics, psychiatric symptoms and cognitive deficits.
Kashiwa Y; Kitabayashi Y; Narumoto J; Nakamura K; Ueda H; Fukui K
Psychiatry Clin Neurosci; 2005 Dec; 59(6):697-704. PubMed ID: 16401246
[TBL] [Abstract][Full Text] [Related]
38. [Cognitive disorders in patients with Huntington's disease].
Barquero-Jiménez MS; Gómez-Tortosa E
Rev Neurol; 2001 Jun 1-15; 32(11):1067-71. PubMed ID: 11562832
[TBL] [Abstract][Full Text] [Related]
39. Rate of change in early Huntington's disease: a clinicometric analysis.
Meyer C; Landwehrmeyer B; Schwenke C; Doble A; Orth M; Ludolph AC;
Mov Disord; 2012 Jan; 27(1):118-24. PubMed ID: 22095693
[TBL] [Abstract][Full Text] [Related]
40. Huntington's disease.
Bonelli RM; Beal MF
Handb Clin Neurol; 2012; 106():507-26. PubMed ID: 22608641
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
